0000950123-17-001896.txt : 20170214 0000950123-17-001896.hdr.sgml : 20170214 20170213213654 ACCESSION NUMBER: 0000950123-17-001896 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170213 EFFECTIVENESS DATE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C. CENTRAL INDEX KEY: 0001439589 IRS NUMBER: 204234752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16125 FILM NUMBER: 17602040 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 781-290-0770 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001439589 XXXXXXXX 12-31-2016 12-31-2016 Polaris Venture Management Co. V, L.L.C.

ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210

13F HOLDINGS REPORT 028-16125 N Max Eisenberg 855-787-3500 Max Eisenberg Boston MA 02-10-2017 0 9 84246 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Atyr Pharma Inc. Common Stock 002120103 3930 1827992 SH SOLE 1827992 0 0 Cerulean Pharma Inc Common Stock 15708Q105 2328 3287529 SH SOLE 3287529 0 0 Fate Therapeutics, Inc. Common Stock 31189P102 6208 2473186 SH SOLE 2473186 0 0 Genocea Biosciences, Inc. Common Stock 372427104 8111 1968606 SH SOLE 1968606 0 0 Ocular Therapeutix, Inc. Common Stock 67576A100 6602 788723 SH SOLE 788723 0 0 Pulmatrix Inc. Common Stock 74584P103 2129 3607996 SH SOLE 3607996 0 0 Selecta Biosciences, Inc. Common Stock 816212104 32999 1924151 SH SOLE 1924151 0 0 T2 Biosystems, Inc. Common Stock 89853L104 9865 1875524 SH SOLE 1875524 0 0 Trevena, Inc. Common Stock 89532E109 12075 2053540 SH SOLE 2053540 0 0